Browsing by Publisher "Ediciones Doyma, S.L."
Now showing 1 - 4 of 4
Results Per Page
Sort Options
Item Assessment of sexual function in women with macromastia and their partners(Ediciones Doyma, S.L., 2015) Üçer O.; Sir E.; Güngör M.; Keçeci Y.; Aksoy A.; Gümüş B.Objective: To investigate the sexual function in patients with macromastia and their partners. Materials and methods: 48 patients with macromastia and 30 healthy controls and their partners were enrolled in the study. The sexual function of the women and their partners was evaluated by using the Index of Female Sexual Function (IFSF) and International Index of Erectile Function (IIEF), respectively. Results: Mean ages of the patients and controls were respectively, 33.27 ± 5.24 and 32.06 ±. 3.91 (p > 0.05). Mean IFSF scores of the patients and controls were 23.21 ± 3.16 and 27.33 ± 4.94 (p = 0.00), respectively. All of the subscale scores of IFSF in the patient group were significantly lower than in the control group. Mean IIEF scores of the patients' and controls' partners were 60.33 ± 11.46 and 65.25 ± 6.18 (p = 0.04), respectively. Conclusion: In this study, Macromastia was shown to affect sexual function of women and their partners adversely. © 2014 Asociación Española de Andrología, Medicina Sexual y Reproductiva.Item Evaluation of sexual function in women with labia minora hypertrophy: A preliminary study; [Evaluación de la función sexual en las mujeres con hipertrofia en los labios vaginales menores: un estudio preliminar](Ediciones Doyma, S.L., 2018) Sir E.; Güngör M.; Üçer O.; Aksoy A.Objective: To compare the sexual functions in women with labia minora hypertrophy and age-matched healthy controls. Material and method: 43 patients with labia minora hypertrophy and 30 age-matched healthy controls were enrolled in the present study. The sexual functions of the women were evaluated by using the index of female sexual function (IFSF). Results: Mean ages of the patients and controls were 30.06 ± 7.11 and 31.34 ± 4.12 (p = 0.41), respectively. Mean total IFSF scores of the patients and controls were 24.18 ± 3.24 and 27.53 ± 4.43 (p < 0.05), respectively. The subscale scores of IFSF-lubrication, orgasm, satisfaction and pain in the patient group were significantly lower than in the control group (respectively, p < 0.001, p < 0.05, p < 0.001 and p < 0.05). There was no statistically significant difference between IFSF-arousal scores of the patient and control groups (p = 0.30). The mean IFSF-desire scores of the patient group was higher than the controls (p < 0.001). Labia minora hypertrophy was significantly associated with female sexual dysfunction (odds ratio [OR] = 14.97, 95% confidence interval [Cl] = [3.66–61.21], p < 0.001). Conclusion: This study suggests that patients with labia minora hypertrophy have poorer lubrication, satisfaction, pain, and orgasm scores on the IFSF scale compared to age-matched healthy controls. © 2017 Asociación Española de Andrología, Medicina Sexual y ReproductivaItem Fabry disease in familial Mediterranean fever according to the severity of the disease; [Enfermedad de Fabry en la fiebre mediterránea familiar según la gravedad de la enfermedad](Ediciones Doyma, S.L., 2024) Uslu S.; Kabadayi G.; Teke Kısa P.; Yüce Inel T.; Arslan Z.; Arslan N.; Akar S.; Onen F.; Sari I.Objectives: Mutations in the α-galactosidase A (GLA) gene result in Fabry disease (FD), a rare metabolic condition. FD patients present with heterogeneous clinical manifestations, which may overlap with systemic diseases including familial Mediterranean fever (FMF). The aim of this study was to determine the frequency of FD in patients with mild and severe FMF and to prevent misdiagnosis by increasing clinicians’ awareness. Methods: Based on Tel-Hashomer criteria, the study included a total of 91 FMF patients. Patients were divided into two groups according to the number of recurrent clinical episodes or failure to respond to maximum therapy: those with mild and severe forms of the disease. GLA gene mutations and α-GLA enzyme activity were assessed. Records of MEFV mutations, therapies and demographic characteristics were kept. Results: FD testing was performed on a cohort of 91 FMF patients, 54.9% had mild FMF, 45.1% had severe FMF, and only one patient in the mild FMF subgroup tested positive for FD. The patient was a 39-year-old woman with a history of recurrent abdominal pain, distal limb pain and fever. She had low GLA enzyme activity and a heterozygous GLA gene mutation. Conclusions: Our findings suggest that FD should be considered in the differential diagnosis of FMF, especially in individuals with unusual symptoms. © 2024 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de ReumatologíaItem Salt-and-pepper appearance of the skin in systemic sclerosis; [Aspecto sal y pimienta de la piel en la esclerosis sistémica](Ediciones Doyma, S.L., 2024) Tasgöz F.C.; Ali Acar E.; Kaçar M.; Soysal Gündüz Ö.; Uslu S.[No abstract available]